Binding of human beta 2-microglobulin to murine EL4 thymoma cells upregulates MHC class I heavy-chain epitopes, inhibits IL-2 secretion and induces resistance to killing by natural killer cells

Immunol Lett. 1994 Feb;39(2):195-202. doi: 10.1016/0165-2478(94)90107-4.

Abstract

A variety of murine tumor cell lines was studied for its binding of exogeneously added human beta 2-microglobulin (h beta 2m). Three T lymphomas and one IL-2-dependent T-cell line (HT-1) bound substantial amounts of h beta 2m, whereas P815 mastocytoma cells, an Abelson virus-infected pre-B cell line (ABLS-8), X63 B-lymphoma cells and YAC cells did not bind h beta 2m. In two of the T lymphomas, EL4 and BW5147, binding of h beta 2m led to an increase in major histocompatibility complex class I (MHC-I) heavy-chain epitope expression as measured by anti-H-2K/D antibody binding and FACS analysis. EL4 cells which had bound h beta 2m decreased their rate of constitutive IL-2 secretion and became resistant to activated natural killer (NK) cell killing. The present data suggest the binding of h beta 2m to mouse T cells leads to conformational changes of MHC-I heavy chains which influence both effector and target functions of the cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytotoxicity, Immunologic / immunology*
  • Epitopes / metabolism*
  • Flow Cytometry
  • Histocompatibility Antigens Class I / metabolism*
  • Interleukin-2 / metabolism*
  • Killer Cells, Natural / immunology*
  • Lymphoma, T-Cell / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, SCID
  • Tumor Cells, Cultured
  • Up-Regulation
  • beta 2-Microglobulin / metabolism*

Substances

  • Epitopes
  • Histocompatibility Antigens Class I
  • Interleukin-2
  • beta 2-Microglobulin